Latest Updates
-
Panchamrit Recipe: A Traditional Temple Delight -
Horoscope for Today April 24, 2026 - Steady Progress & Practical Choices -
Restaurant Style Paneer Masala Recipe for a Perfect Dinner -
Bagalamukhi Jayanti 2026 Date: When ‘Dhurandhar’ Fame Aditya Dhar Visited Bagalamukhi Temple With Yami Gautam -
Ritesh Bawri’s Journey from 14 Near-Death Experiences to Reversing Chronic Illness -
Crispy South Indian Snack: The Ultimate Medu Vada Recipe -
Who Is Sadhvi Satish Sail? The Journey From Goa To Miss India World 2026 Crown -
Makeup Hacks 101: How to Keep Your Makeup Fresh in Summer Without Overdoing It -
Maharashtra Restaurants Must Declare Fake Paneer From May 1: How To Spot Fake Vs Real Paneer -
Asthma, Medication, and Weight: Why Anant Ambani May Not Be Losing Weight Easily
Drug For Menstrual Problems

Menstrual cramps, also known as dysmenorrhea, creates several problems which include the pain in abdomen and back, nausea, mood swings, vomiting, sweating, and dizziness for ninety percent of the women. Menstrual cramps are caused by contractions of the uterus during menstruation. In dysmenorrhea, the uterus contracts with increased frequency, causing unusually severe, cramping pain. The reason for this is the increased blood levels of the hormone Vasopressin, which plays a role in regulating contraction of the uterus. The newly developed drug helps blocking the hormones, which can relieve dysmenorrhea.
Existing treatments for the condition include pain-relievers, anti-inflammatory drugs, and oral contraceptives that stop menstruation. These treatments are ineffective in almost one-third of women with moderate to severe cases. Some of them relieve only the symptoms, rather than targeting the underlying cause of dysmenorrhea, and may have unwanted side effects such as mood alteration and stomach upsets.
The newly developed drug, VAIII913, can fine tune the effects of dysmenorrhea. This drug is to be administered orally as a pill, rather than an injection. The drug is safe, with no apparent ill effects.
The next phase of clinical trials is currently underway in the U.K. and the U.S. to evaluate how well it works to control pain in a group of women with dysmenorrhea.
Investigators expect results to be available later this year. If studies continue to show promise, the drug could be available to patients in four years, says the scientists.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications